NanoViricides, Inc. (NNVC): A typical nanoviricides drug is designed like a chemical missile. It has a number of recognition "ligands" on its surface, that are specific to a single type of virus, say HIV. They are like the GPS on a directed missile. They will identify the enemy and attach to specific "landing sites" on the enemy target. The nanoviricides drug, after landing, spreads itself all over the virus particle, and thus completely neutralizes and disables the virus particle from binding to its target, a human cell.
Information and Disclosure Statements: Pursuant to Rule 15c2-11 October 19, 2006 tinyurl.com FORM 10-SB/A February 14, 2007 tinyurl.com
Website: nanoviricides.com DD Links tinyurl.com
Patents: PCT/US06/01820 Applied:Jan 19, 2006 PCT Solubilization and Targeted Delivery of Drugs with Selfassembling Amphiphilic Polymers 10SB12G knobias.10kwizard.com
The targets: We currently have, in early, active development, products against H5N1 (Avian Flu), common Human Influenza (both highly pathogenic and non pathogenic), Rabies, and Hepatitis C. We plan on undertaking the development of drugs against other viruses when adequate financing becomes available. The Company's ability to achieve progress in the drugs in development is dependent upon available financing and upon the Company's ability to raise capital. |
